Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 15/20 | 0.57 |
| ▸ | MAP3K12 | Q12852 | 2/20 | 0.54 |
| ▸ | PIK3CB | P42338 | 3/20 | 0.50 |
| ▸ | PIK3CD | O00329 | 3/20 | 0.50 |
| ▸ | PIK3R1 | P27986 | 2/20 | 0.50 |
| ▸ | AKT1 | P31749 | 1/20 | 0.50 |
| ▸ | PIK3CG | P48736 | 2/20 | 0.47 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.47 |
| ▸ | MTOR | P42345 | 2/20 | 0.47 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.47 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13848165 | 0.90 | PIK3CA (0.55) | PIK3CAMAP3K12PIK3CBPIK3CDPIK3R1 | |
| SCHEMBL4123927 | 0.88 | PIK3CA (0.58) | PIK3CAMAP3K12PIK3CBPIK3CDPIK3R1 | |
| SCHEMBL3995666 | 0.85 | PIK3CA (0.57) | PIK3CAMAP3K12PIK3CBPIK3CDPIK3R1 | |
| SCHEMBL3988513 | 0.84 | PIK3CA (0.61) | PIK3CAMAP3K12PIK3CBPIK3CDPIK3R1 | |
| SCHEMBL3998898 | 0.84 | MAP4K4 (0.54) | PIK3CAMAP3K12PIK3CBPIK3CDPIK3R1 | |
| SCHEMBL4123039 | 0.83 | PIK3CA (0.50) | PIK3CAMAP3K12PIK3CBPIK3CDPIK3R1 | |
| SCHEMBL4127391 | 0.81 | PIK3CA (0.59) | PIK3CAMAP3K12PIK3CBPIK3CDPIK3R1 | |
| SCHEMBL3993858 | 0.81 | AOC3 (0.52) | PIK3CAMAP3K12PIK3CBPIK3CDPIK3R1 | |
| SCHEMBL3994777 | 0.80 | PIK3CA (0.72) | PIK3CAMAP3K12PIK3CBPIK3CDPIK3R1 | |
| SCHEMBL10327831 | 0.79 | PIK3CA (0.49) | PIK3CAMAP3K12PIK3CBPIK3CDPIK3R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009066084-A1 | 2 -MORPHOLINOPYRIMIDINES AND THEIR USE AS PI3 KINASE INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2009-05-28 | — | — | WO | claimed |